Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine and TPVB for Pain and Cognitive Function in Thoracoscopic Surgery
NCT05341375Completed
- Sponsor
- The First Hospital of Qinhuangdao
- Start
- Apr 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of esketamine in Post-operative cognitive dysfunction (POCD) and postoperative pain (4 arms), sponsored by The First Hospital of Qinhuangdao. Primary endpoints: Incidence of Postoperative Cognitive Dysfunction and Visual Analogue Scale for Pain. Started Apr 2021; status: completed.
02
Drugs
esketamine
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative pain
Beyond the preview
Go deeper on NCT05341375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05341375.